Decades have passed since the first nanoparticles-base medicine was approved for human
cancer treatment, and the research and development of nanoparticles for drug delivery are …

Poor targeting of therapeutics leading to severe adverse effects on normal tissues is
considered one of the obstacles in cancer therapy. To help overcome this, nanoscale drug …

Nitric oxide (NO), a gaseous transmitter extensively present in the human body, regulates
vascular relaxation, immune response, inflammation, neurotransmission, and other crucial …

Bacterial infection often induces chronic repair of wound healing owing to aggravated
inflammation. Hydrogel dressing exhibiting intrinsic antibacterial activity may substantially …

MXenes (viz., transition metal carbides, carbonitrides, and nitrides) have emerged as a new
subclass of 2D materials. Due to their outstanding physicochemical and biological …

Photothermal therapy (PTT), which utilizes near‐infrared light‐absorbing agents to ablate
tumor, has emerged as a highly promising anticancer strategy and received intensive …

One of the main challenges for immune checkpoint blockade antibodies lies in malignancies
with limited T-cell responses or immunologically “cold” tumors. Inspired by the capability of …

Studies of nanosized forms of bismuth (Bi)-containing materials have recently expanded
from optical, chemical, electronic, and engineering fields towards biomedicine, as a result of …

The antitumor efficiency and clinical translation of traditional nanomedicines is mainly
restricted by low drug loading, complex preparation technology, and potential toxicity …

The highly immunosuppressive tumor microenvironment (TME) in solid tumors often
dampens the efficacy of immunotherapy. In this study, bacterial outer membrane vesicles …